Clinical Trials Unit, Ontario Child Health Support Unit, The Hospital for Sick Children, Toronto, ON, Canada.
Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
CJEM. 2021 Sep;23(5):646-654. doi: 10.1007/s43678-021-00108-9. Epub 2021 Mar 21.
While electrolyte maintenance solution is recommended and commonly used in pediatric gastroenteritis, it can be more costly and less palatable than preferred fluids such as apple juice.
To assess the incremental cost-effectiveness of apple juice/preferred fluids versus electrolyte maintenance solution in reducing treatment failures in children in an emergency department from societal and health care perspectives.
A probabilistic cost-effectiveness analysis was performed using clinical trial and chart data. All intervention, and direct and indirect costs were included, with a 14-day time horizon. Cost-effectiveness was examined by calculating the difference in mean number of treatment failures and mean cost/patient between treatment groups. The probabilistic point estimate and 95% confidence intervals for incremental costs and incremental effectiveness were determined.
The apple juice strategy was less costly than electrolytes with average per child savings of CAD $171 (95% CI $22 to $1097) from a societal perspective, and $147 (95% CI $23 to $1056) from a health care perspective. There were 0.08 fewer treatment failures per child (95% CI - 0.15 to - 0.02). The higher electrolyte maintenance solution cost was due to more frequent hospitalizations, ongoing care, and greater lost parental productivity due to additional medical visits.
Apple juice/preferred fluids strategy was dominant over electrolytes in the treatment of children with minimal dehydration secondary to acute gastroenteritis as this option yielded fewer treatment failures and a lower societal cost. Given the high prevalence of acute gastroenteritis, this approach may result in significant cost savings while leading to improved clinical outcomes.
虽然电解质维持液在儿科肠胃炎中被推荐并广泛使用,但它比苹果汁等首选液体更昂贵,口感也较差。
从社会和医疗保健角度评估苹果汁/首选液体与电解质维持液在减少急诊科儿童治疗失败方面的增量成本效益。
使用临床试验和图表数据进行概率成本效益分析。所有干预、直接和间接成本均包括在内,时间范围为 14 天。通过计算治疗组之间治疗失败的平均数量和每位患者的平均成本差异来检查成本效益。确定增量成本和增量效果的概率点估计值和 95%置信区间。
从社会角度看,苹果汁策略比电解质策略每儿童平均节省 CAD$171(95%CI:22 至 1097),从医疗保健角度看,每儿童平均节省 CAD$147(95%CI:23 至 1056)。每个孩子的治疗失败次数减少 0.08 次(95%CI:-0.15 至 -0.02)。电解质维持液成本较高的原因是住院次数增加、持续护理以及因额外医疗就诊而导致的父母生产力损失增加。
在治疗因急性肠胃炎而出现轻度脱水的儿童时,苹果汁/首选液体策略优于电解质策略,因为该方案可减少治疗失败次数,并降低社会成本。鉴于急性肠胃炎的高患病率,这种方法可能会节省大量成本,同时带来更好的临床效果。